Iranian Journal of Allergy, Asthma and Immunology 2016. 15(6):547-550.

A Case of Anaphylaxis to Patent Blue in a Patient with Sentinel Lymph Node Excision
Stefanie Aurich, Anna-Theresa Seitz, Janina Tomm, Jan-Christoph Simon, Regina Treudler

Abstract


In medicine, patent blue violet (PBV) is utilized for staining lymphatic vessels in sentinel lymph node (SLN) surgery. Moreover, PBV (also called E131 ) is used as food additive. We report on a 51-year-old non-atopic female with early breast cancer, who was scheduled for SLN excision and experienced an intra-operative anaphylactic reaction. In diagnostics the skin prick test (SPT) was positive to PBV. Hypersensitivity reactions to PBV can arise after the first exposure in surgery as sensitization may arise from either PBV (E131) in foods (i.e. in sweets or blue curacao) or from other structurally closely related triarylmethane dyes in objects of everyday life like textiles, detergents, paints, cold remedies and cosmetics. This article supports the necessity of an increased awareness of the possibility of anaphylactic reactions to PBV during SLN surgery, even if the patient never had contact to PBV before.


Keywords


Allergy; Anaphylaxis; Blue dye; Breast cancer; Patent blue violet; Sentinel lymph node excision; E131

Full Text:

PDF

References


1.   Sinclair  DJ,  Perera  FA.  Allergic  reactions:  following patent  blue  dye  injection.  Can  Med  Assoc  J  1969;101(10):100-1.

2.   Gonzalez-Estrada A, Pien LC, Zell K, Wang XF, Lang DM. Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States. J Allergy Clin Immunol Pract 2015; 3(1):101-5.

3.   Mansouri   R,   Chicken   DW,   Kehtgar   MR.   Allergic reactions to patent blue dye. Surg Oncol 2006; 15(1):58

4. Krishna MT, York M, Chin T, Gnanakumaran G, Heslegrave  J,  Derbridge  C,  et  al.  Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase. Clin Exp Immunol 2014; 178(2):399-404.

5.   Brenet O, Lalourcey L, Queinnec M, Dupoiron D, Jayr C, Rosay H, et al. Hypersensitivity reactions to Patent Blue V  in  breast  cancer  surgery:  a  prospective  multicentre study. Acta Anaesthesiol Scand 2013; 57(1):106-11.

6.   Beenen E, de Roy van Zuidewijn DB. Patients blue on patent blue: adverse reaction during four sentinel node procedures. Surg Oncol 2005; 14(4):151-4.

7. Hunting AS, Nopp A, Johansson SG, Andersen F, Wilhelmsen V, Guttormsen  AB. Anaphylaxis to  patent blue V. I. Clinical aspects. Allergy 2010; 65(1):117-23.

8.   Haque RA, Wagner A, Whiskeen JA, Nasser SM, Ewan PW. Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy 2010; 65(3):396-400.

9.   Mertes PM, Malinovsky JM, Mouton-Faivre C, Bonnet- Boyer MC, Benhaijoub A, Lavaud F, et al. Anaphylaxis o dyes  during  the  perioperative  period:  reports  of  14 clinical cases. J Allergy Clin Immunol 2008; 122(2):348-52

10. Wöhrl S, Focke M, Hinterhuber G, Stingl G, Binder M.Near fatal anaphylaxis to patent blue V. Br J Dermatol

2004; 150(5):1037-8

11. Johansson SG, Nopp A, Oman H, Stahl-Skov P, Hunting AS, Guttormsen AB. Anaphylaxis to patent blue V. II. A

unique IgE-mediated reaction. Allergy 2010; 65(1):124-9.

12. Scherer   K,   Studer   W,   Figueiredo   V,   Bircher   AJ.Anaphylaxis  to  isosulfan  blue  and  cross-reactivity  to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006;96(3):497-500.

13. Longnecker  SM,  Guzzardo  MM,  Van  Voris  LP.  Life threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm 1985;4(2):219-21

14. Forschner K, Kleine-Tebbe A, Zuberbier T, Worm M.Type I sensitization towards patent blue as a cause of anaphylaxis. Allergy 2003; 58(5):457–8.

15.  Montgomery LL, Thorne AC, Van Zee KJ, Fey J, Heerdt AS, Gemignani M, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anaesth Analg 2002; 95(2):385-8.

16. Nour A. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients. Breast J 2004; 10(5):388-91.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.